Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) requiring chiral piperazine scaffolds. Its protected amine functionality and hydroxyl group allow for selective modifications in multi-step organic syntheses. Commonly employed in the preparation of bioactive molecules, including central nervous system agents and metabolic disorder therapeutics. The compound’s stereochemistry supports high selectivity in receptor binding during drug design. Suitable for use in coupling reactions and as a building block in combinatorial chemistry for drug discovery.